Red Spruce Capital LLC acquired a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 15,987 shares of the pharmacy operator’s stock, valued at approximately $943,000.
A number of other large investors have also recently made changes to their positions in the business. Jacobs Levy Equity Management Inc. lifted its position in Walgreens Boots Alliance by 1,116.2% during the 2nd quarter. Jacobs Levy Equity Management Inc. now owns 80,150 shares of the pharmacy operator’s stock worth $4,382,000 after buying an additional 73,560 shares in the last quarter. AMP Capital Investors Ltd boosted its holdings in shares of Walgreens Boots Alliance by 4.4% in the 2nd quarter. AMP Capital Investors Ltd now owns 354,653 shares of the pharmacy operator’s stock valued at $19,334,000 after buying an additional 15,026 shares during the last quarter. Private Advisor Group LLC boosted its holdings in shares of Walgreens Boots Alliance by 4.3% in the 2nd quarter. Private Advisor Group LLC now owns 27,196 shares of the pharmacy operator’s stock valued at $1,487,000 after buying an additional 1,120 shares during the last quarter. Prospera Financial Services Inc bought a new stake in Walgreens Boots Alliance in the 2nd quarter valued at $232,000. Finally, Compagnie Lombard Odier SCmA raised its stake in Walgreens Boots Alliance by 1.4% in the 2nd quarter. Compagnie Lombard Odier SCmA now owns 19,395 shares of the pharmacy operator’s stock valued at $1,061,000 after acquiring an additional 260 shares during the period. 60.37% of the stock is owned by hedge funds and other institutional investors.
In other news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $63.16, for a total transaction of $14,801,861.80. Following the sale, the chief accounting officer now directly owns 13,844 shares of the company’s stock, valued at $874,387.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 16.91% of the company’s stock.
WBA has been the topic of a number of research analyst reports. Wells Fargo & Co cut Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, December 11th. SunTrust Banks increased their price target on Walgreens Boots Alliance from $58.00 to $60.00 and gave the company a “hold” rating in a research note on Wednesday, December 18th. Mizuho reiterated a “hold” rating and set a $59.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, January 9th. Royal Bank of Canada cut Walgreens Boots Alliance to a “hold” rating and set a $59.00 price objective on the stock. in a research report on Friday, September 27th. Finally, BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Friday, December 13th. Five equities research analysts have rated the stock with a sell rating and fifteen have issued a hold rating to the company. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $58.69.
Shares of NASDAQ WBA opened at $54.43 on Thursday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.31 and a current ratio of 0.66. Walgreens Boots Alliance Inc has a 52 week low of $49.03 and a 52 week high of $74.94. The stock has a market capitalization of $48.39 billion, a P/E ratio of 9.09, a PEG ratio of 1.34 and a beta of 0.90. The stock’s fifty day moving average is $58.07 and its 200 day moving average is $55.66.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, January 8th. The pharmacy operator reported $1.37 EPS for the quarter, missing the Zacks’ consensus estimate of $1.40 by ($0.03). Walgreens Boots Alliance had a return on equity of 21.76% and a net margin of 2.69%. The company had revenue of $34.34 billion during the quarter, compared to the consensus estimate of $34.45 billion. During the same quarter in the previous year, the business posted $1.46 EPS. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. Equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.87 earnings per share for the current year.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Monthly Dividend Stocks Can Provide Solid Income
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.